[A retrospective controlled study of TACE-HAIC-targeted-immune quadruple therapy for intermediate and advanced-stage hepatocellular carcinoma].

医学 肝细胞癌 内科学 胃肠病学 阶段(地层学) 比例危险模型 联合疗法 对数秩检验 不利影响 肿瘤科 生存分析 入射(几何) 生物 光学 物理 古生物学
作者
L Li,Jiao He,Yuping Xie,X H Huang,Xiadi Weng,Xinting Pan,Yubin Jiao,Hou-bing Zheng,Luzhen Qiu,Wanping Guo
出处
期刊:PubMed 卷期号:30 (9): 939-946
标识
DOI:10.3760/cma.j.cn501113-20220823-00432
摘要

Objective: To evaluate the efficacy and safety of transcatheter arterial chemoembolization (TACE)-hepatic arterial infusion chemotherapy (HAIC)-targeted-immune quadruple therapy in patients with intermediate and advanced-stage hepatocellular carcinoma (HCC). Methods: 101 patients with intermediate and advanced stage HCC were enrolled according to the inclusion and exclusion criteria, and then they were divided into a combination group and a control group. Patients in the combination group was treated with TACE-HAIC-targeted-immune quadruple therapy, while the control group was only treated with TACE therapy. The overall survival (OS), progression-free survival (PFS), and treatment-related adverse reactions were statistically analyzed in the two groups of patients. Statistical analysis was carried out by t-test, χ2 test, rank sum test, Kaplan-Meier curve, log-rank test, Cox regression (or proportional hazards model) analysis according to different data. Results: The tumor objective response rate and disease control rate as evaluated by mRECIST 1.1 criteria in the combination group were 80% and 94%, respectively, which were significantly higher than those in the control group, 41.2% (P<0.001) and 74.5% (P=0.007). The OS and PFS of the combination group were 15.6 months [95%CI 11.3-NA ] and 8.8 months [95%CI 6.9-12.0], respectively, which were significantly better than the control group at 6.1 months [95%CI 5.3-6.6] (P<0.001) and 3.2 months [95%CI 3.0-3.6] (P<0.001). Gastric ulcer incidence was significantly higher in the combination group (9/50, 18%) than that in the control group (2/51, 3.9%) (P=0.023). Conclusion TACE-HAIC-targeted-immune quadruple therapy is a more effective treatment mode for intermediate and advanced-stage HCC than TACE alone, and attention should be paid to the monitoring of target immune-related adverse reactions.目的: 评价经导管动脉化疗栓塞术(TACE)-肝动脉灌注化疗(HAIC)-靶向-免疫四联治疗中晚期肝细胞癌(HCC)患者的疗效和安全性。 方法: 根据入排标准入组101例中晚期HCC患者,分为联合组和对照组。联合组患者行TACE-HAIC-靶向-免疫四联治疗,对照组患者仅接受TACE治疗。对2组患者的总生存期(OS)、无疾病进展生存期(PFS)、治疗相关的不良反应进行统计分析。据资料不同采用t检验、χ2检验、秩和检验、Kaplan-Meier曲线、对数秩检验、Cox回归分析或Cox比例风险模型分析进行统计学分析。 结果: 以mRECIST 1.1标准评估联合组肿瘤客观缓解率和疾病控制率分别为80%和94%,明显高于对照组的41.2%(P<0.001)和74.5%(P=0.007)。联合组的OS和PFS为15.6(95%CI 11.3~NA)个月和8.8(95%CI 6.9~12.0)个月,明显优于对照组的6.1(95%CI 5.3~6.6)个月(P<0.001)和3.2(95%CI 3.0~3.6)个月(P<0.001)。联合组胃溃疡发生率(9/50,18%)比对照组(2/51,3.9%)明显增加(P=0.023)。 结论: TACE-HAIC-靶向-免疫四联治疗对比单纯TACE治疗是一种更有效的中晚期HCC治疗方式,需注意对靶免治疗相关不良反应的监测。.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
简单而复杂完成签到,获得积分10
刚刚
tigger发布了新的文献求助10
刚刚
刚刚
王灿灿发布了新的文献求助10
1秒前
ran完成签到,获得积分10
1秒前
Superu应助good琳采纳,获得10
1秒前
爱嘤嘤嘤斯坦完成签到,获得积分10
2秒前
2秒前
2秒前
kyt完成签到,获得积分10
3秒前
4秒前
果茶发布了新的文献求助200
5秒前
科研通AI2S应助医学林采纳,获得10
5秒前
5秒前
Maestro_S应助努力的学采纳,获得10
5秒前
Maestro_S应助雪儿采纳,获得10
6秒前
6秒前
7秒前
Lucas应助心灵美的花卷采纳,获得10
7秒前
复杂尔蓝发布了新的文献求助10
7秒前
完美世界应助小五采纳,获得10
8秒前
8秒前
充电宝应助熙若白采纳,获得10
9秒前
9秒前
山河与海发布了新的文献求助10
9秒前
深情安青应助亦犹未进采纳,获得10
10秒前
金雪发布了新的文献求助10
10秒前
10秒前
情怀应助枯木逢春采纳,获得10
10秒前
小夏发布了新的文献求助10
11秒前
11秒前
奶昔应助乌拉拉拉拉采纳,获得10
11秒前
七_发布了新的文献求助10
11秒前
大个应助千灯采纳,获得10
11秒前
完美世界应助务实的樱桃采纳,获得10
11秒前
12秒前
心灵美的花卷完成签到,获得积分10
13秒前
纪南风完成签到,获得积分10
13秒前
张鑫关注了科研通微信公众号
14秒前
14秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
ALA生合成不全マウスでの糖代謝異常の分子機構解析 520
Aspects of Babylonian celestial divination: the lunar eclipse tablets of Enūma Anu Enlil 500
Mathematics and Finite Element Discretizations of Incompressible Navier—Stokes Flows 500
2024 Medicinal Chemistry Reviews 400
Dictionary of socialism 350
Mixed-anion Compounds 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3198170
求助须知:如何正确求助?哪些是违规求助? 2847101
关于积分的说明 8062182
捐赠科研通 2512034
什么是DOI,文献DOI怎么找? 1343836
科研通“疑难数据库(出版商)”最低求助积分说明 639640
邀请新用户注册赠送积分活动 609302